David A. Evans
Plus aucun poste en cours
Profil
David A.
Evans served as President & Chief Executive Officer at Clinical Data Interchange Standards Consortium, Inc. from 2021 to 2024.
Prior to that, he was Chief Information Officer at Octagon Research Solutions, Inc. and Chief Technology Officer at First Genetic Trust, Inc. Evans holds a graduate degree from Drexel University and an undergraduate degree from Ursinus College.
Anciens postes connus de David A. Evans
| Sociétés | Poste | Fin |
|---|---|---|
Clinical Data Interchange Standards Consortium, Inc.
 Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Directeur Général | 02/01/2024 |
First Genetic Trust, Inc.
 First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Directeur Technique/Scientifique/R&D | - |
Octagon Research Solutions, Inc.
 Octagon Research Solutions, Inc. Information Technology ServicesTechnology Services Octagon Research Solutions, Inc. provides software services to the pharmaceutical sectors. The company was founded by James C. Walker in 1999 and is headquartered in King of Prussia, PA. | Directeur Technique/Scientifique/R&D | - |
Formation de David A. Evans
| Ursinus College | Undergraduate Degree |
| Drexel University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Octagon Research Solutions, Inc.
Octagon Research Solutions, Inc. Information Technology ServicesTechnology Services Octagon Research Solutions, Inc. provides software services to the pharmaceutical sectors. The company was founded by James C. Walker in 1999 and is headquartered in King of Prussia, PA. | Technology Services |
First Genetic Trust, Inc.
First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Health Services |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Commercial Services |
